FDA advisory committee recommends approval of Bepreve for allergic conjunctivitis
Links shared publicly online about this topic.
- 1,941total visits
FDA advisory committee recommends approval of Bepreve for allergic conjunctivitis
IRVINE, Calif. - The U.S. Food and Drug Administration Dermatologic and Ophthalmic Drugs Advisory Committee has recommended the approval of bepotastin
View full resource at osnsupersite.com
Tags: Allergies, Eye Allergy, Dermatology, Eye Infection, Conjunctivitis, Drug, FDA
Most Recently Shared on June 26, 2009 at 3:10 pm By:
FDA advisory committee recommends approval of Bepreve for allergic conjunctivitis: http://ow.ly/fV88
FDA Approves Bepreve for the Treatment of Itching Associated With Allergic Conjunctivitis
eyedocnews.com — “FDA committee unanimously approved Bepreve eye drops after reviewing the safety and efficacy information from the clinical studies.” View full resource at eyedocnews.com
Most Recently Shared on June 30, 2009 at 2:49 am By:
Dr. Ari Weitzner Physician, Doctor, and Ophthalmologist
Discuss: Bepreveâ„¢ Eye Drops from ISTA Obtain Approval of FDA Dermatologic and Ophthalmic Drugs Advisory .. http://tinyurl.com/n6a5aw
Advertisement
